comparemela.com

Latest Breaking News On - Micafungin sodium - Page 1 : comparemela.com

Gland Pharma soars 5% on in-line Q2 results; should buy, hold or sell the stock?

Gland Pharma earnings have bottomed out and are on track to recovery with stable pricing and volume-led growth across geographies, said Jefferies.

Motilal oswalGland pharmaRocuronium bromideEnoxaparin sodiumMicafungin sodiumUpside scenarioGland pharma q2 earningsLand pharma q2 earnings newsAtest gland pharma q2 earnings updatesLand pharma q2 earnings latest newsLand pharma q2 earnings latest updatesLand pharma companies q2 earningsGland pharma q2 resultsLand pharma q2 results updatesLand pharma q2 results newsLand pharma latest q2 results updates

Sandoz concludes acquisition of antifungal agent Mycamine from Astellas

Basel: Sandoz has successfully completed the acquisition of worldwide brand rights for systemic antifungal agent Mycamine (micafungin sodium, Funguard in Japan) from Astellas.Through this acquisition.

Richard saynorSandoz newsMicafungin sodiumInvasive candidiasisEsophageal candidiasis

vimarsana © 2020. All Rights Reserved.